[Gln11]-beta-Amyloid (1-40) introduces a residue capable of forming alternative hydrogen-bonding patterns, affecting β-sheet initiation. This adjustment makes the peptide useful for studying early nucleation events in aggregation. Its behavior under varying solvent environments provides insights into peptide-water interactions. The variant is routinely used in structural and biophysical investigations of amyloid formation.
CAT No: A13272
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More